108 related articles for article (PubMed ID: 16816919)
1. Phosphodiesterase 4 inhibitor rolipram potentiates the inhibitory effect of calcitonin on osteoclastogenesis.
Miyamoto K; Nishioka T; Waki Y; Nomura M; Katsuta H; Yokogawa K; Amano H
J Bone Miner Metab; 2006; 24(4):260-5. PubMed ID: 16816919
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of osteoclastogenesis by a phosphodiesterase 4 inhibitor XT-611 through synergistic action with endogenous prostaglandin E2.
Yamagami H; Nishioka T; Ochiai E; Fukushima K; Nomura M; Kasugai S; Moritani S; Yokogawa K; Miyamoto K
Biochem Pharmacol; 2003 Sep; 66(5):801-7. PubMed ID: 12948861
[TBL] [Abstract][Full Text] [Related]
3. Rolipram, a phosphodiesterase 4 inhibitor, stimulates osteoclast formation by inducing TRANCE expression in mouse calvarial cells.
Cho ES; Yu JH; Kim MS; Yim M
Arch Pharm Res; 2004 Dec; 27(12):1258-62. PubMed ID: 15646801
[TBL] [Abstract][Full Text] [Related]
4. Rolipram, a phosphodiesterase 4 inhibitor, suppresses PGE2-induced osteoclast formation by lowering osteoclast progenitor cell viability.
Park H; Yim M
Arch Pharm Res; 2007 Apr; 30(4):486-92. PubMed ID: 17489366
[TBL] [Abstract][Full Text] [Related]
5. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.
Marcoz P; Prigent AF; Lagarde M; Nemoz G
Mol Pharmacol; 1993 Nov; 44(5):1027-35. PubMed ID: 8246905
[TBL] [Abstract][Full Text] [Related]
6. Role of phosphodiesterase 4 isoenzyme in alkaline phosphatase activation by calcitonin in porcine kidney LLC-PK1 cells.
Miyamoto K; Suzuki R; Horita T; Yamamoto S; Waki Y; Takagi K
Jpn J Pharmacol; 1998 Feb; 76(2):193-8. PubMed ID: 9541282
[TBL] [Abstract][Full Text] [Related]
7. Rolipram, a phosphodiesterase 4 inhibitor, prevented cancellous and cortical bone loss by inhibiting endosteal bone resorption and maintaining the elevated periosteal bone formation in adult ovariectomized rats.
Yao W; Tian XY; Chen J; Setterberg RB; Lundy MW; Chmielzwski P; Froman CA; Jee WS
J Musculoskelet Neuronal Interact; 2007; 7(2):119-30. PubMed ID: 17627081
[TBL] [Abstract][Full Text] [Related]
8. Calcitonin inhibits osteoclast formation in mouse haematopoetic cells independently of transcriptional regulation by receptor activator of NF-{kappa}B and c-Fms.
Granholm S; Lundberg P; Lerner UH
J Endocrinol; 2007 Dec; 195(3):415-27. PubMed ID: 18000304
[TBL] [Abstract][Full Text] [Related]
9. Phosphodiesterase 4 inhibition synergizes with relaxin signaling to promote decidualization of human endometrial stromal cells.
Bartsch O; Bartlick B; Ivell R
J Clin Endocrinol Metab; 2004 Jan; 89(1):324-34. PubMed ID: 14715868
[TBL] [Abstract][Full Text] [Related]
10. Stimulation of beta adrenoceptors in a human monocyte cell line (U937) up-regulates cyclic AMP-specific phosphodiesterase activity.
Torphy TJ; Zhou HL; Cieslinski LB
J Pharmacol Exp Ther; 1992 Dec; 263(3):1195-205. PubMed ID: 1335058
[TBL] [Abstract][Full Text] [Related]
11. The phosphodiesterase type 4 inhibitor, rolipram, enhances glucocorticoid receptor function.
Miller AH; Vogt GJ; Pearce BD
Neuropsychopharmacology; 2002 Dec; 27(6):939-48. PubMed ID: 12464451
[TBL] [Abstract][Full Text] [Related]
12. Effect of the phosphodiesterase 4 inhibitor, rolipram, on retinoic acid-increased alkaline phosphatase activity in the mouse fibroblastic C3H10T1/2 cell line.
Murata T; Sugatani T; Shimizu K; Manganiello VC; Tagawa T
Arch Oral Biol; 2003 Jan; 48(1):63-7. PubMed ID: 12615143
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of PDE3B augments PDE4 inhibitor-induced apoptosis in a subset of patients with chronic lymphocytic leukemia.
Moon E; Lee R; Near R; Weintraub L; Wolda S; Lerner A
Clin Cancer Res; 2002 Feb; 8(2):589-95. PubMed ID: 11839681
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-10 does not mediate the inhibitory effect of PDE-4 inhibitors and other cAMP-elevating drugs on lipopolysaccharide-induced tumors necrosis factor-alpha generation from human peripheral blood monocytes.
Seldon PM; Barnes PJ; Giembycz MA
Cell Biochem Biophys; 1998; 29(1-2):179-201. PubMed ID: 9631245
[TBL] [Abstract][Full Text] [Related]
15. Effects of rolipram, a phosphodiesterase 4 inhibitor, in combination with imipramine on depressive behavior, CRE-binding activity and BDNF level in learned helplessness rats.
Itoh T; Tokumura M; Abe K
Eur J Pharmacol; 2004 Sep; 498(1-3):135-42. PubMed ID: 15363987
[TBL] [Abstract][Full Text] [Related]
16. Effects of rolipram on in vivo dopamine receptor binding.
Hosoi R; Ishikawa M; Kobayashi K; Gee A; Yamaguchi M; Inoue O
J Neural Transm (Vienna); 2002 Sep; 109(9):1139-49. PubMed ID: 12203041
[TBL] [Abstract][Full Text] [Related]
17. Pregnancy induces a modulation of the cAMP phosphodiesterase 4-conformers ratio in human myometrium: consequences for the utero-relaxant effect of PDE4-selective inhibitors.
Méhats C; Tanguy G; Paris B; Robert B; Pernin N; Ferré F; Leroy MJ
J Pharmacol Exp Ther; 2000 Feb; 292(2):817-23. PubMed ID: 10640323
[TBL] [Abstract][Full Text] [Related]
18. Interaction between the antidepressant-like behavioral effects of beta adrenergic agonists and the cyclic AMP PDE inhibitor rolipram in rats.
Zhang HT; Huang Y; Mishler K; Roerig SC; O'Donnell JM
Psychopharmacology (Berl); 2005 Oct; 182(1):104-15. PubMed ID: 16010541
[TBL] [Abstract][Full Text] [Related]
19. Phosphodiesterase 4 inhibitor regulates the TRANCE/OPG ratio via COX-2 expression in a manner similar to PTH in osteoblasts.
Park H; Young Lee S; Lee DS; Yim M
Biochem Biophys Res Commun; 2007 Mar; 354(1):178-83. PubMed ID: 17222389
[TBL] [Abstract][Full Text] [Related]
20. Phosphodiesterase (PDE) 7 in inflammatory cells from patients with asthma and COPD.
Jones NA; Leport M; Holand T; Vos T; Morgan M; Fink M; Pruniaux MP; Berthelier C; O'Connor BJ; Bertrand C; Page CP
Pulm Pharmacol Ther; 2007; 20(1):60-8. PubMed ID: 16427796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]